
Adam J. Schoenfeld, MD
Thoracic Oncologist, Cellular Therapist & Early Drug Development Specialist
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
Request an Appointment
About Me
- Assistant Attending Physician
I am a medical oncologist devoted to caring for people with lung cancer, as well as bringing novel immunotherapy strategies to patients with solid tumors.
I work closely with a multidisciplinary team including radiation oncology, thoracic surgery, pulmonology, and pathology, among others, to identify a personalized treatment plan tailored to each patient’s case and circumstances. We also lead many clinical trials, which are open to patients who are interested and eligible.
We know that receiving a diagnosis of cancer is daunting. My team and I are committed to supporting each patient and their family through their experience with cancer and will work together to provide them with the highest level of care. From our initial visit onward, we are here for our patients and will spend as much time as needed to ensure that everyone understands and is in agreement with the care plan.
Read more
My research focuses on using innovative strategies to harness a person’s own immune system to treat cancer. I am a member of the Cellular Therapeutics Center, where I design and lead early phase clinical trials that use genetically engineered versions of a patient’s immune cells as living drugs to fight their cancer. I work closely with the scientists who pioneered these techniques to bring cutting-edge approaches to difficult-to-treat tumors.
My Specialties
- Lung Cancer
- Immunotherapy
- Adoptive Cellular Therapy
- Clinical Trials
Education
- MD, University of California, San Francisco
Residencies
- Internal Medicine - University of California, San Francisco
Awards and Honors
- Conquer Cancer Career Development Award, Conquer Cancer Foundation of the American Society of Clinical Oncology (2022)
- Young Investigator Award, American Society of Clinical Oncology & Conquer Cancer Foundation (2019)
- Conquer Cancer Foundation Merit Award, American Society of Clinical Oncology Annual Meeting (2019, 2020)
Fellowships
- Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
- Internal Medicine
- Oncology
Insurance Information
Understanding your insurance options is an important part of managing your cancer care. We have relationships with many common healthcare providers and plans.
In Network Coverage Type
PPO
In Network Coverage Type
HMO, PPO
In Network Coverage Type
HMO, EPO PPO, POS
In Network Coverage Type
PPO
In Network Coverage Type
EPO
In Network Coverage Type
EPO
In Network Coverage Type
Federal Government
In Network Coverage Type
PPO, POS, EPO, HMO
In Network Coverage Type
State Government
Don't see your carrier or plan? We can help you understand your coverage.
If you don't have health insurance or are worried that your care may not be fully covered, our financial assistance programs may be able to help.
If you have questions about insurance, call us at 646-497-9176.
Make an Appointment

New Patients
Current Patients
Contact and Location
Dr. Schoenfeld sees patients at two locations.
Looking to see a doctor at a different location? See all MSK locations.
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
See all Cellular Therapy Service doctors
Clinical Trials
- Clinical Trials Investigated by Dr. Schoenfeld
- A Phase I Study of STK-012 Alone and with Pembrolizumab Immunotherapy in People with Solid Tumors
- A Phase I/IIA Study of ATL001 with or without Pembrolizumab Immunotherapy in People with Non-Small Cell Lung Cancer
- A Phase II Study of Autologous Tumor-Infiltrating Lymphocyte Immunotherapy in People with Metastatic Melanoma or Lung Cancer
- A Phase II Study of LN-145 Immunotherapy in People with Metastatic Non-Small-Cell Lung Cancer
Read more
- Clinical Trials Co-Investigated by Dr. Schoenfeld
- A Phase 1 Study of PRT3789 in People With Solid Tumors
- A Phase I Study of ADP-A2M4CD8 with or without Nivolumab Immunotherapy in People with Urothelial Cancer, Non-Small Cell Lung Cancer, or Endometrial Cancer
- A Phase I Study of AGEN1811 and Balstilimab Immunotherapy in People with Fibrolamellar Carcinoma or Another Type of Gastrointestinal Cancer
- A Phase I Study of CAR T-Cell Immunotherapy for Pleural Mesothelioma
- A Phase I/II Study of IOV-4001 in People with Inoperable or Metastatic Melanoma or Non-Small Cell Lung Cancer
- A Pilot Study of Lifileucel in People with Metastatic Melanoma to the Brain that Is Not Causing Symptoms
- A Pilot Study of LN-144 Immunotherapy in People with Metastatic Uveal Melanoma
- Expanded Access to Lifileucel to Treat Inoperable or Metastatic Melanoma

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Schoenfeld’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
Your trust is our main concern
We strive to keep reviews trustworthy, honest and fair. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Adam J. Schoenfeld discloses the following relationships and financial interests:
-
Amgen
Professional Services and Activities -
Bristol-Myers Squibb
Professional Services and Activities -
Enara Bio Limited
Professional Services and Activities -
Heat Biologics, Inc.
Professional Services and Activities -
Immunocore
Professional Services and Activities -
Iovance Biotherapeutics, Inc.
Professional Services and Activities -
Johnson & Johnson
Professional Services and Activities
-
KSQ Therapeutics
Professional Services and Activities -
Legend Biotech USA Inc.
Professional Services and Activities -
Lyell Immunopharma, Inc.
Professional Services and Activities -
Merck & Co Inc.
Professional Services and Activities -
Perceptive Advisors, LLC
Professional Services and Activities -
Prelude Therapeutics
Professional Services and Activities -
Umoja Biopharma, Inc.
Professional Services and Activities
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2022 through disclosure submission in spring 2023). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].